• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SPCA2的表观遗传调控逆转乳腺癌细胞的上皮-间质转化

Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells.

作者信息

Makena Monish Ram, Ko Myungjun, Dang Donna Kimberly, Rao Rajini

机构信息

Department of Physiology, Johns Hopkins University School of Medicine, 725 N. Wolfe St, Baltimore, MD 21205, USA.

出版信息

Cancers (Basel). 2021 Jan 12;13(2):259. doi: 10.3390/cancers13020259.

DOI:10.3390/cancers13020259
PMID:33445642
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7827456/
Abstract

The secretory pathway Ca-ATPase SPCA2 is a tumor suppressor in triple receptor negative breast cancer (TNBC), a highly aggressive molecular subtype that lacks tailored treatment options. Low expression of SPCA2 in TNBC confers poor survival prognosis in patients. Previous work has established that re-introducing SPCA2 to TNBC cells restores basal Ca signaling, represses mesenchymal gene expression, mitigates tumor migration in vitro and metastasis in vivo. In this study, we examined the effect of histone deacetylase inhibitors (HDACi) in TNBC cell lines. We show that the pan-HDACi vorinostat and the class I HDACi romidepsin induce dose-dependent upregulation of SPCA2 transcript with concurrent downregulation of mesenchymal markers and tumor cell migration characteristic of epithelial phenotype. Silencing SPCA2 abolished the ability of HDACi to reverse epithelial to mesenchymal transition (EMT). Independent of ATPase activity, SPCA2 elevated resting Ca levels to activate downstream components of non-canonical Wnt/Ca signaling. HDACi treatment led to SPCA2-dependent phosphorylation of CAMKII and β-catenin, turning Wnt signaling off. We conclude that SPCA2 mediates the efficacy of HDACi in reversing EMT in TNBC by a novel mode of non-canonical Wnt/Ca signaling. Our findings provide incentive for screening epigenetic modulators that exploit Ca signaling pathways to reverse EMT in breast tumors.

摘要

分泌途径Ca-ATP酶SPCA2是三受体阴性乳腺癌(TNBC)中的一种肿瘤抑制因子,TNBC是一种侵袭性很强的分子亚型,缺乏针对性的治疗方案。TNBC中SPCA2的低表达预示着患者的生存预后较差。先前的研究已经证实,将SPCA2重新导入TNBC细胞可恢复基础钙信号,抑制间充质基因表达,减轻体外肿瘤迁移和体内转移。在本研究中,我们检测了组蛋白去乙酰化酶抑制剂(HDACi)对TNBC细胞系的影响。我们发现,泛HDACi伏立诺他和I类HDACi罗米地辛可诱导SPCA2转录本的剂量依赖性上调,同时下调间充质标志物和具有上皮表型特征的肿瘤细胞迁移。沉默SPCA2消除了HDACi逆转上皮-间充质转化(EMT)的能力。不依赖于ATP酶活性,SPCA2提高静息钙水平以激活非经典Wnt/Ca信号的下游成分。HDACi处理导致CAMKII和β-连环蛋白的SPCA2依赖性磷酸化,从而关闭Wnt信号。我们得出结论,SPCA2通过一种新的非经典Wnt/Ca信号模式介导HDACi在TNBC中逆转EMT的功效。我们的研究结果为筛选利用钙信号通路逆转乳腺肿瘤EMT的表观遗传调节剂提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/c3fb558cbbb5/cancers-13-00259-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/aec71c020301/cancers-13-00259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/66b3642327e1/cancers-13-00259-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/fdd3b44233c7/cancers-13-00259-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/924df1ed9baf/cancers-13-00259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/214e57b275bc/cancers-13-00259-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/6b2974bb3505/cancers-13-00259-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/c3fb558cbbb5/cancers-13-00259-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/aec71c020301/cancers-13-00259-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/66b3642327e1/cancers-13-00259-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/fdd3b44233c7/cancers-13-00259-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/924df1ed9baf/cancers-13-00259-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/214e57b275bc/cancers-13-00259-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/6b2974bb3505/cancers-13-00259-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7940/7827456/c3fb558cbbb5/cancers-13-00259-g007.jpg

相似文献

1
Epigenetic Modulation of SPCA2 Reverses Epithelial to Mesenchymal Transition in Breast Cancer Cells.SPCA2的表观遗传调控逆转乳腺癌细胞的上皮-间质转化
Cancers (Basel). 2021 Jan 12;13(2):259. doi: 10.3390/cancers13020259.
2
Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors.DNA 甲基转移酶和组蛋白去乙酰化酶抑制剂对三阴性乳腺癌细胞上皮间质转化的表观遗传重编程。
J Exp Clin Cancer Res. 2018 Dec 14;37(1):314. doi: 10.1186/s13046-018-0988-8.
3
A Ca-ATPase Regulates E-cadherin Biogenesis and Epithelial-Mesenchymal Transition in Breast Cancer Cells.钙-ATP 酶调节乳腺癌细胞中 E-钙黏蛋白的生物发生和上皮-间充质转化。
Mol Cancer Res. 2019 Aug;17(8):1735-1747. doi: 10.1158/1541-7786.MCR-19-0070. Epub 2019 May 10.
4
Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.小豆蔻明,一种查尔酮,通过下调Wnt/β-连环蛋白信号级联反应和逆转上皮-间质转化来抑制人三阴性乳腺癌细胞的侵袭性。
Biofactors. 2017 Mar;43(2):152-169. doi: 10.1002/biof.1315. Epub 2016 Sep 1.
5
Shikonin inhibits triple-negative breast cancer-cell metastasis by reversing the epithelial-to-mesenchymal transition via glycogen synthase kinase 3β-regulated suppression of β-catenin signaling.紫草素通过糖原合酶激酶 3β 调控的β-连环蛋白信号抑制抑制作用逆转上皮间质转化,从而抑制三阴性乳腺癌细胞转移。
Biochem Pharmacol. 2019 Aug;166:33-45. doi: 10.1016/j.bcp.2019.05.001. Epub 2019 May 6.
6
The natural compound Jatrophone interferes with Wnt/β-catenin signaling and inhibits proliferation and EMT in human triple-negative breast cancer.天然化合物麻风树素干扰Wnt/β-连环蛋白信号传导并抑制人三阴性乳腺癌的增殖和上皮-间质转化。
PLoS One. 2017 Dec 27;12(12):e0189864. doi: 10.1371/journal.pone.0189864. eCollection 2017.
7
NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling.NUMB通过拮抗Notch信号通路负向调控三阴性乳腺癌的上皮-间质转化。
Oncotarget. 2016 Sep 20;7(38):61036-61053. doi: 10.18632/oncotarget.11062.
8
SPCA2 couples Ca influx via Orai1 to Ca uptake into the Golgi/secretory pathway.SPCA2将通过Orai1的钙离子内流与钙离子摄取到高尔基体/分泌途径相偶联。
Tissue Cell. 2017 Apr;49(2 Pt A):141-149. doi: 10.1016/j.tice.2016.09.004. Epub 2016 Sep 17.
9
Secretory pathway Ca-ATPase SPCA2 regulates mitochondrial respiration and DNA damage response through store-independent calcium entry.分泌途径 Ca-ATP 酶 SPCA2 通过非储存依赖的钙内流调节线粒体呼吸和 DNA 损伤反应。
Redox Biol. 2022 Apr;50:102240. doi: 10.1016/j.redox.2022.102240. Epub 2022 Jan 17.
10
Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling.低剂量紫杉醇联合 XAV939 通过抑制 Wnt 信号通路抑制乳腺癌转移、血管生成和生长。
Cells. 2019 Aug 14;8(8):892. doi: 10.3390/cells8080892.

引用本文的文献

1
Wnt/Ca signaling: Dichotomous roles in regulating tumor progress (Review).Wnt/Ca信号传导:在调节肿瘤进展中的双重作用(综述)
Oncol Lett. 2025 Jun 18;30(2):399. doi: 10.3892/ol.2025.15145. eCollection 2025 Aug.
2
LINC01116 affects patient survival differently and is dissimilarly expressed in ER+ and ER- breast cancer samples.LINC01116 对 ER+和 ER-乳腺癌样本的患者生存影响不同,且表达情况也不同。
Cancer Rep (Hoboken). 2023 Aug;6(8):e1848. doi: 10.1002/cnr2.1848. Epub 2023 Jun 15.
3
Transcriptional Basis of Ca Remodeling Reversal Induced by Polyamine Synthesis Inhibition in Colorectal Cancer Cells.

本文引用的文献

1
Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies.伏立诺他和维甲酸在T细胞淋巴恶性肿瘤的临床前模型中具有协同作用。
Anticancer Drugs. 2021 Jan 1;32(1):34-43. doi: 10.1097/CAD.0000000000001008.
2
Regulation of Wnt Signaling through Ubiquitination and Deubiquitination in Cancers.Wnt 信号通路在癌症中的泛素化和去泛素化调控。
Int J Mol Sci. 2020 May 30;21(11):3904. doi: 10.3390/ijms21113904.
3
The β-catenin/YAP signaling axis is a key regulator of melanoma-associated fibroblasts.β-连环蛋白/YAP 信号轴是黑色素瘤相关成纤维细胞的关键调节因子。
多胺合成抑制诱导大肠癌细胞钙重塑逆转的转录基础
Cancers (Basel). 2023 Mar 4;15(5):1600. doi: 10.3390/cancers15051600.
4
CRAC and SK Channels: Their Molecular Mechanisms Associated with Cancer Cell Development.钙释放激活钙(CRAC)通道和小电导钙激活钾(SK)通道:它们与癌细胞发育相关的分子机制
Cancers (Basel). 2022 Dec 23;15(1):101. doi: 10.3390/cancers15010101.
5
Targeting epigenetic regulators for inflammation: Mechanisms and intervention therapy.针对炎症的表观遗传调节因子:作用机制与干预疗法
MedComm (2020). 2022 Sep 15;3(4):e173. doi: 10.1002/mco2.173. eCollection 2022 Dec.
6
Expression and associated epigenetic mechanisms of the Ca-signaling genes in breast cancer subtypes and epithelial-to-mesenchymal transition.钙信号基因在乳腺癌亚型及上皮-间质转化中的表达及相关表观遗传机制
J Cell Commun Signal. 2022 Sep;16(3):461-474. doi: 10.1007/s12079-021-00655-x. Epub 2021 Nov 11.
Signal Transduct Target Ther. 2019 Dec 24;4:63. doi: 10.1038/s41392-019-0100-7. eCollection 2019.
4
Subtype specific targeting of calcium signaling in breast cancer.乳腺癌中钙信号的亚型特异性靶向。
Cell Calcium. 2020 Jan;85:102109. doi: 10.1016/j.ceca.2019.102109. Epub 2019 Nov 12.
5
Wnt/β-Catenin Signaling: The Culprit in Pancreatic Carcinogenesis and Therapeutic Resistance.Wnt/β-连环蛋白信号通路:胰腺癌发生和治疗抵抗的罪魁祸首。
Int J Mol Sci. 2019 Aug 30;20(17):4242. doi: 10.3390/ijms20174242.
6
Risk stratification of triple-negative breast cancer with core gene signatures associated with chemoresponse and prognosis.三阴性乳腺癌的核心基因特征与化疗反应和预后相关的风险分层。
Breast Cancer Res Treat. 2019 Nov;178(1):185-197. doi: 10.1007/s10549-019-05366-x. Epub 2019 Jul 24.
7
A Ca-ATPase Regulates E-cadherin Biogenesis and Epithelial-Mesenchymal Transition in Breast Cancer Cells.钙-ATP 酶调节乳腺癌细胞中 E-钙黏蛋白的生物发生和上皮-间充质转化。
Mol Cancer Res. 2019 Aug;17(8):1735-1747. doi: 10.1158/1541-7786.MCR-19-0070. Epub 2019 May 10.
8
Effective and new potent drug combination: Histone deacetylase and Wnt/β-catenin pathway inhibitors in lung carcinoma cells.有效且新型的强效药物组合:组蛋白去乙酰化酶和 Wnt/β-连环蛋白通路抑制剂在肺癌细胞中的作用。
J Cell Biochem. 2019 Sep;120(9):15467-15482. doi: 10.1002/jcb.28813. Epub 2019 Apr 29.
9
Store-independent Orai1-mediated Ca entry and cancer.无储存依赖型 Orai1 介导的钙内流与癌症。
Cell Calcium. 2019 Jun;80:1-7. doi: 10.1016/j.ceca.2019.02.012. Epub 2019 Mar 7.
10
Panobinostat (LBH589) inhibits Wnt/β-catenin signaling pathway via upregulating APCL expression in breast cancer.帕比司他(LBH589)通过上调乳腺癌中 APCL 的表达抑制 Wnt/β-连环蛋白信号通路。
Cell Signal. 2019 Jul;59:62-75. doi: 10.1016/j.cellsig.2019.03.014. Epub 2019 Mar 14.